Back

Q&A

3 April 2025 (08:00 - 19:00)
Organised by: Logo
Congress Presentation Part of: From risk assessment to action: the role of icosapent ethyl in cardiovascular risk management Secondary Prevention Open Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

4 More presentations in this session

Presentation thumbnail
Clinical Case Introduction
Professor V. Aboyans (Monaco, MC)
Slides Video
Presentation thumbnail
U-Prevent: a personalized approach to cardiovascular risk management
Doctor J. Dorresteijn (Utrecht, NL)
Slides
Presentation thumbnail
Understanding the clinical benefit of icosapent ethyl: insights from REDUCE-IT
Doctor H. Contractor (Manchester, GB)
Slides Video
Presentation thumbnail
Key takeaways: addressing residual cardiovascular risk with proven therapies
Professor G. De Ferrari (Turin, IT)
Slides Video

Access the full session

Session thumbnail
From risk assessment to action: the role of icosapent ethyl in cardiovascular risk management
Video

The Event

Event poster

ESC Preventive Cardiology 2025

3 April - 5 April 2025
You may be interested in
thumbnail
Congress Presentation
Making personalised prevention everyone's business
thumbnail
Congress Presentation
Should we intervene early in patients with asymptomatic aortic stenosis?
thumbnail
Congress Presentation
Cardiovascular prevention in older adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources